Market Cap
$4.8B
+2.4% today
Sector & Industry
Healthcare
Pharmaceuticals
SEC Filings
140
Total filings on record
Last Filing
Feb 1, 2026
8-K — Board of Directors Update
Showing 15 filings
| Form Type | Filed Date | Accepted | Description | Accession | Actions |
|---|---|---|---|---|---|
| 10-K | Feb 1, 2026 | Feb 1, 2026 | Annual Report for fiscal year ended March 2025 | 0008855001-26-724622 | |
| 10-K | Jan 2, 2026 | Jan 2, 2026 | Annual Report for fiscal year ended January 2025 | 0008855001-26-621274 | |
| 10-Q | Nov 26, 2025 | Nov 26, 2025 | Quarterly Report for period ended September 2025 | 0008855001-26-318796 | |
| 8-K | Nov 5, 2025 | Nov 5, 2025 | Current Report - Material Event Disclosure | 0008855001-26-526524 | |
| 8-K | Oct 11, 2025 | Oct 11, 2025 | Current Report - Material Event Disclosure | 0008855001-26-519943 | |
| Form 4 | Sep 9, 2025 | Sep 9, 2025 | Statement of Changes - James Johnson | 0008855001-26-464611 | |
| 13F | Aug 11, 2025 | Aug 11, 2025 | Institutional Investment Manager Holdings Report | 0008855001-26-222394 | |
| 10-Q | Jul 11, 2025 | Jul 11, 2025 | Quarterly Report for period ended September 2025 | 0008855001-26-811849 | |
| 8-K | Jun 21, 2025 | Jun 21, 2025 | Current Report - Material Event Disclosure | 0008855001-26-636744 | |
| 10-K | May 25, 2025 | May 25, 2025 | Annual Report for fiscal year ended March 2025 | 0008855001-26-204483 | |
| 10-Q | Apr 17, 2025 | Apr 17, 2025 | Quarterly Report for period ended March 2025 | 0008855001-25-536467 | |
| 8-K | Mar 24, 2025 | Mar 24, 2025 | Current Report - Material Event Disclosure | 0008855001-25-537641 | |
| DEF 14A | Feb 25, 2025 | Feb 25, 2025 | Definitive Proxy Statement for Annual Meeting | 0008855001-25-986795 | |
| 10-K | Jan 25, 2025 | Jan 25, 2025 | Annual Report for fiscal year ended December 2025 | 0008855001-25-217233 | |
| 10-K | Jan 5, 2025 | Jan 5, 2025 | Annual Report for fiscal year ended December 2025 | 0008855001-25-767796 |